Lobbying Activity Report

204-50526

Organization: AstraZeneca Canada Inc.
Associated registration: 10233-204-38
Lobbying Activity date: 2026-03-17
Arranged a meeting: Yes
Posted date: 2026-04-15

In-house lobbyists who participated in the lobbying activity: Derek Badger
Senior Public Office Holders who were lobbied in this activity: Tyler Norman, Chief of Staff
Minister's Office, Finance
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Discussions with BC Government officials including the Ministry of Finance , organizations and elected representatives to discuss funding for AZ's innovation pharmaceuticals and biopharmaceuticals. To encourage the BC government and various ministries to recognize the importance of investments made in R&D within the province and how these investments lead to the health development of BC's health ecosystem. Discussions with BC Government officials to discuss the global policy shifts such as the U.S. Most Favoured Nation approach, so that they are contextualized not only as pricing issues, but as broader strategic risks to launch timing, clinical trials, investment, and Canada’s health innovation capacity.
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Finances and Budgets
 
Senior officer who filed this Lobbying Activity Report: Gaby Bourbara
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.

Return to Registration for Wildsight
Date Modified: